Health Policy & Advocacy
Resources
Basic InformationMore InformationLatest News
Electronic Health Records Bogging Docs DownMore Are Seeking Mental Health Care, But Not Always Those Who Need It MostMillions of Americans Still Breathing Secondhand Smoke: ReportNew Approach to Opioid Crisis: Supervised Heroin Injection Programs?Many Americans Unaware of Promise of Targeted, 'Personalized' Medicine: PollAs Gun Violence Grows, U.S. Life Expectancy DropsMost Americans Lie to Their DoctorsOpioid Crisis, Suicides Driving Decline in U.S. Life Expectancy: CDCWant to Learn CPR? Try an Automated KioskHealth Surrogates Often in Dark About Loved One's WishesRestaurant 'Health Grade' Posters Could Mean Safer DiningSmoking Bans Might Help Nonsmokers' Blood PressureWarmer Winters, More Violent Crimes?Are Food Additives Good or Bad? Consumer Views VaryDrug Studies in Children Often Go Unfinished: StudyFDA Moves to Restrict Flavored E-Cig Sales, Ban Menthol CigarettesAgeism Costs Billions in Health Care DollarsAmerica Is Worried About Antibiotic ResistanceRed Cross Issues Urgent Call for Blood Ahead of the HolidaysUnder Pressure, Juul Withdraws Most Flavored E-Cigs From MarketMany Drugstores Won't Dispense Opioid Antidote as RequiredNew Cholesterol Guidelines Focus on Personalized ApproachAHA: Defibrillators Can Help Kids Survive Cardiac Arrest, TooFDA Will Ban Many Flavored E-CigarettesU.S. Smoking Rates Hit Record LowOnly a Quarter of Opioid Painkillers Taken After Most SurgeriesHome Health-Care Tests: Proceed With CautionFDA Takes on Flatulent CowsWhy Bystanders Are Less Likely to Give CPR to WomenCellphone Radiation Tied to Upped Odds for Cancer -- in RatsHealth Tip: FDA Discusses Possible Risks of Bodybuilding ProductsU.S. Hospitals Making Headway Against InfectionsAfter Mass Shootings, Blood Donations Can Go UnusedLead in Hair Dyes Must Go: FDAIn California, Some Doctors Sell 'Medical Exemptions' for Kids' VaccinationsGot Unused Prescription Meds? Saturday Is National Drug Take-Back DayFDA Too Quick to Call BPA Chemical Safe, Health Experts SayIs Crowdfunding Too Often Used for Bogus Treatments?Many Supplements Still Contain Dangerous Stimulants: StudyTapping Into TelehealthMenthol Cig Ban Didn't Spur Black Market Sales: StudyHip-Hop Loaded With Pot, Cigarette ReferencesWhite House Wants Prices in Drug Ads, But Big Pharma Fights BackMany Supplements Contain Unapproved, Dangerous Ingredients: StudyE-Cigs Continue to Spark Debate Over Health Risks/BenefitsClinical Trials Need More VolunteersGetting Your Medical Records Might Not Be EasyMost People Don't Know if They Have Genetic Risk for CancerConsumer Reports Says Warnings About Tainted Beef Don't Go Far EnoughThe Physician Assistant Will See You Now
Questions and AnswersVideosLinksBook Reviews
Related Topics

Health Insurance
Healthcare

Drug Studies in Children Often Go Unfinished: Study

HealthDay News
by -- Robert Preidt
Updated: Nov 19th 2018

new article illustration

MONDAY, Nov. 19, 2018 (HealthDay News) -- Drug approvals for adults often require future studies in children, but many of these studies are never completed, a new analysis finds.

"More than 50 percent of all drugs approved by the FDA lack information on how to safely and effectively use the drug in children," said study author Dr. Florence Bourgeois, from the Pediatric Therapeutics and Regulatory Science Initiative at Boston Children's Hospital.

Her team examined 114 new drugs or new uses for drugs that were approved by the U.S. Food and Drug Administration between 2007 and 2014. In all, a total of 222 postmarketing studies in children were required for these approvals.

But only 34 percent of those studies had been completed by December 2017. Of those completed, only 45 percent had results reported in a journal.

At the time of FDA approval, only 16 percent of the drugs approved with postmarketing child studies had any information on child-related efficacy, safety or dosing on their labels. This rose to only 41 percent after an average follow-up of seven years.

"As a clinician, I was struck early on by how little evidence we often have to guide medication use in children. Although the FDA has an established process to ensure medicines are safe and effective in adults, this has historically been lacking for children," Bourgeois said in a hospital news release.

"Unfortunately, we are still seeing long delays between the approval of a drug and the availability of pediatric information. This perpetuates off-label drug use that may be unsafe or ineffective," she said.

Additional FDA oversight and use of enforcement tools are needed to ensure follow-up studies are completed, the researchers said.

The study was published Nov. 19 in the journal JAMA Pediatrics.

More information

The U.S. Food and Drug Administration has more on postmarketing clinical trials.




Facebook

Amazon Smile

To quit smoking, call Connecticut QuitLine at 1-800-QUIT-NOW.

Children and Adult services are available now with no wait time.  Please contact HBH Intake Department at 860-548-0101, option 2.

 


powered by centersite dot net